Science Advances
Supplementary Materials
This PDF file includes:
- fig. S1. Characterization of BC samples used in genome-wide analyses.
- fig. S2. TET1 and immune markers in non-BLBC BC subtypes.
- fig. S3. TET1 expression and immunity in BLBC.
- fig. S4. Non-BLBC subtypes do not show a strong correlation between TET1 expression and immunity.
- fig. S5. Immune pathways modulate TET1 expression in BC.
- fig. S6. Activation of NF-κB in BC cells.
- fig. S7. NF-κB and TET1 in additional BC cell lines.
- fig. S8. Immunity and TET2 and TET3 in BLBC.
- fig. S9. TET1 promoter and streptavidin-agarose pulldown probes.
- fig. S10. TET1 and immunity in thyroid, melanoma, and lung cancers.
- fig. S11. TET1 and immunity in additional cancer types.
- fig. S12. TET1 expression and NF-κB in additional cancer types.
- Legend for table S1
- table S2. Genes negatively correlating with TET1 in BLBC (TCGA)—Top 5 of gene ontology categories.
- table S3. Genes positively correlating with TET1 in BLBC (TCGA)—Top 5 of gene ontology categories.
- table S4. List of primers.
Other Supplementary Material for this manuscript includes the following:
- table S1. List of dhmRs in BLBC (Excel file).
Files in this Data Supplement: